Daniel Janney Insider Trading Activity
Daniel Janney has been net-selling over the last 12 months with 0 purchases and 22 sales across 1 company.
KRYS is the most-traded position with 22 trades. The largest single transaction was a sale of KRYS for $3.1M on Feb 24, 2026.
Performance Scorecard
Forward stock performance after each transaction by Daniel Janney. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | +7.0% | 100% | 22 |
| 90 days | — | -12.9% | 0% | 22 |
| 120 days | — | -31.2% | 0% | 22 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersKRYS · Krystal Biotech, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Daniel Janney bought and sold KRYS.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Feb 27, 2026 | KRYS | Sell | 9,430 | $275.45 | $2.6M | −11.1% | Director | |
Feb 27, 2026 | KRYS | Sell | 2,373 | $276.17 | $655K | −3.1% | Director | |
Feb 26, 2026 | KRYS | Sell | 2,638 | $276.32 | $729K | −3.0% | Director | |
Feb 26, 2026 | KRYS | Sell | 5,103 | $275.28 | $1.4M | −5.5% | Director | |
Feb 25, 2026 | KRYS | Sell | 700 | $275.00 | $193K | −0.7% | Director | |
Feb 24, 2026 | KRYS | Sell | 8,986 | $266.18 | $2.4M | −28.0% | Director | |
Feb 24, 2026 | KRYS | Sell | 11,673 | $266.97 | $3.1M | −50.6% | Director | |
Feb 24, 2026 | KRYS | Sell | 6,671 | $268.04 | $1.8M | −58.6% | Director | |
Feb 24, 2026 | KRYS | Sell | 3,963 | $268.97 | $1.1M | −84.2% | Director | |
Feb 24, 2026 | KRYS | Sell | 370 | $269.83 | $100K | −49.8% | Director | |
Feb 24, 2026 | KRYS | Sell | 373 | $271.09 | $101K | −100.0% | Director | |
Feb 24, 2026 | KRYS | Sell | 62 | $263.05 | $16K | −0.1% | Director | |
Feb 24, 2026 | KRYS | Sell | 900 | $264.60 | $238K | −0.8% | Director | |
Feb 24, 2026 | KRYS | Sell | 1,604 | $265.54 | $426K | −1.5% | Director | |
Feb 24, 2026 | KRYS | Sell | 4,339 | $266.62 | $1.2M | −4.1% | Director | |
Feb 24, 2026 | KRYS | Sell | 1,891 | $267.37 | $506K | −1.9% | Director | |
Feb 24, 2026 | KRYS | Sell | 1,674 | $268.67 | $450K | −1.7% | Director | |
Feb 24, 2026 | KRYS | Sell | 930 | $269.50 | $251K | −1.0% | Director | |
Feb 24, 2026 | KRYS | Sell | 2,425 | $274.90 | $667K | −2.5% | Director | |
Feb 24, 2026 | KRYS | Sell | 569 | $262.91 | $150K | −1.5% | Director | |
Feb 24, 2026 | KRYS | Sell | 3,557 | $265.08 | $943K | −10.0% | Director | |
Feb 24, 2026 | KRYS | Sell | 1,733 | $264.12 | $458K | −4.6% | Director |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| KRYS | Krystal Biotech, Inc. | 22 | $19.4M |
Other insiders at Krystal Biotech, Inc.
3 other tracked filers at KRYS.